🔗 Permalink

Inventor profile of:

Jonathan Powell

City:

Baltimore, Maryland

Country:

United States

Published Applications:

Last publication date:

2024-05-30

Top Assignees for applications by Jonathan Powell

The entities that hold a legal rights for patent applications filed by inventor Powell Jonathan:

THE JOHNS HOPKINS UNIVERSITY 10 Baltimore, MD United States
ST. JUDE CHILDREN'S RESEARCH HOSPITAL INC. 3 Memphis, TN United States
St. Jude's Children's Research Hospital Inc. 3 Memphis, TN United States
Ústav organické chemie a biochemie AV {hacek over (C)}R, v.v.i. 2 Prague, Czech Republic

Recent patent applications by Powell Jonathan

Jonathan Powell from Baltimore, US has applied for patents for these inventions. The list has both pending applications and granted patents:

#1 | 2024-05-30

US20240174747A1

Chemistry; metallurgy

T CELL REGULATION

#2 | 2023-07-13

US20230218581A1

Human necessities

COMPOSITIONS AND METHODS COMPRISING DENDRIMERS AND THERAPEUTIC AGENTS

#3 | 2021-07-29

US20210230275A1

Chemistry; metallurgy

T CELL REGULATION

#4 | 2021-05-20

US20210145779A1

Human necessities

Methods for cancer and immunotherapy using prodrugs of glutamine analogs

#5 | 2019-07-18

US20190216757A1

Human necessities

Methods for cancer and immunotherapy using prodrugs of glutamine analogs

#6 | 2018-09-06

US20180251550A1

Chemistry; metallurgy

Methods of increasing T cell immune response in the treatment of cancer

#7 | 2018-08-09

US20180221395A1

Human necessities

METHODS FOR CANCER AND IMMUNOTHERAPY USING PRODRUGS OF GLUTAMINE ANALOGS

#8 | 2018-08-09

US20180221337A1

Human necessities

Methods and compositions for treating metabolic reprogramming disorders

#9 | 2016-11-24

US20160339091A1

Human necessities

Methods and compositions for enhanced cellular selectivity using nanocarrier-associated ligands

#10 | 2016-04-21

US20160108121A1

Chemistry; metallurgy

Methods for treatment comprising an antibody that binds CD223 protein

#11 | 2014-05-08

US20140127226A1

Human necessities

T Cell Regulation

#12 | 2013-04-18

US20130095114A1

Human necessities

Method for treating cancer with an antibody to CD223 protein

#13 | 2010-08-05

US20100196394A1

Chemistry; metallurgy

Anti-cancer vaccine composition comprising an anti-CD223 antibody and kit comprising an anti-cancer vaccine and an anti-CD223 antibody

#14 | 2006-10-26

US20060240024A1

Chemistry; metallurgy

T cell regulation

InventorID:

196721 ⎘